Oxler Private Wealth
ABBV icon

Oxler Private Wealth’s AbbVie ABBV Stock Holding History

Oxler Private Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.55M Buy
17,397
+117
+0.7% +$30K 1.22% 18
2026
Q2 		$4.35M Sell
17,280
-34
-0.2% -$7.32K 1.24% 17
2026
Q1 		$3.77M Buy
17,314
+121
+0.7% +$26.8K 1.18% 21
2025
Q4 		$3.93M Buy
17,193
+119
+0.7% +$27.1K 1.14% 19
2025
Q3 		$3.95M Buy
17,074
+72
+0.4% +$14.7K 1.15% 20
2025
Q2 		$3.16M Buy
17,002
+147
+0.9% +$27.3K 0.99% 22
2025
Q1 		$3.53M Buy
16,855
+140
+0.8% +$27.2K 1.24% 23
2024
Q4 		$2.97M Buy
16,715
+44
+0.3% +$8.09K 0.98% 23
2024
Q3 		$3.29M Buy
16,671
+133
+0.8% +$24.8K 1.15% 23
2024
Q2 		$2.84M Buy
16,538
+158
+1% +$26.2K 1.05% 24
2024
Q1 		$2.98M Buy
16,380
+13,122
+403% +$2.26M 1.17% 22
2023
Q4 		$505K Sell
3,258
-12,788
-80% -$1.86M 0.42% 42
2023
Q3 		$2.39M Buy
16,046
+142
+0.9% +$20.8K 1.2% 24
2023
Q2 		$2.14M Sell
15,904
-42
-0.3% -$6.16K 1.02% 28
2023
Q1 		$2.54M Buy
15,946
+151
+1% +$23.1K 1.25% 24
2022
Q4 		$2.55M Buy
+15,795
New +$2.42M 1.37% 25
2022
Q3 		– Sell
-15,495
Closed -$2.37M – 435
2022
Q2 		$2.37M Buy
15,495
+149
+1% +$22.8K 1.14% 26
2022
Q1 		$2.49M Buy
15,346
+148
+1% +$21.5K 1.12% 25
2021
Q4 		$2.06M Hold
15,198
– – 0.85% 33
2021
Q3 		$1.64M Hold
15,198
– – 0.72% 38
2021
Q2 		$1.71M Hold
15,198
– – 0.75% 41
2021
Q1 		$1.64M Buy
15,198
+4,473
+42% +$478K 0.83% 34
2020
Q4 		$1.15M Buy
+10,725
New +$1.03M 0.65% 36

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return
Alecta Tjanstepension Omsesidigt
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $24.1B AUM 30.72% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

Oxler Private Wealth's ABBV Position: Q3 2026 in Review

Oxler Private Wealth increased its AbbVie (ABBV) stake by 0.68% in Q3 2026, buying an estimated $30K and bringing the position to 17,397 shares worth $4.55M. The position accounts for 1.22% of the portfolio, ranked #18.

Oxler Private Wealth first reported a position in ABBV in Q4 2020 and has held it in 23 quarters since. 2,067 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Oxler Private Wealth held 17,397 shares of AbbVie worth $4.55M as of Q3 2026.
  • Oxler Private Wealth bought 117 AbbVie shares in Q3 2026, an estimated $30K.
  • AbbVie made up 1.22% of Oxler Private Wealth's portfolio in Q3 2026, its #18 holding.
  • Oxler Private Wealth first reported a position in AbbVie in Q4 2020 and has held it in 23 quarters since.
  • 2,067 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Oxler Private Wealth's 13F filing for Q3 2026, filed 21 Oct 2026.